<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence and severity of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and <z:hpo ids='HP_0000238'>hydrocephalus</z:hpo> following induced <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> in an experimental group of animals that subsequently received <z:chebi fb="0" ids="16586">epsilon-aminocaproic acid</z:chebi> was compared to that seen in a control group that received no antifibrinolytic therapy </plain></SENT>
<SENT sid="1" pm="."><plain>No augmentation of either vasospasm or <z:hpo ids='HP_0000238'>hydrocephalus</z:hpo> could be attributed to the <z:chebi fb="0" ids="16586">epsilon-aminocaproic acid</z:chebi> in the treated as compared to the control group </plain></SENT>
</text></document>